JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Servatius, R. J.
Right arrow Articles by Natelson, B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Servatius, R. J.
Right arrow Articles by Natelson, B. H.

Vol. 287, Issue 3, 1020-1028, December 1998

Persistently Exaggerated Startle Responses in Rats Treated with Pyridostigmine Bromide1

Richard J. Servatius , John E. Ottenweller , Dawn Beldowicz, Weidun Guo, Guanping Zhu and Benjamin H. Natelson

Department of Neuroscience, New Jersey Medical School (R.J.S., J.E.O., W.G., G.Z., B.H.N.) and Department of Veterans Affairs, New Jersey Health Care System (R.J.S., J.E.O., D.B., B.H.N.), East Orange, New Jersey

Troops in the Persian Gulf War have registered complaints consistent with CNS dysfunction that emerged after returning from the Gulf. A common experience among Persian Gulf War veterans was exposure to pyridostigmine bromide (PB) for prophylaxis against nerve gas exposure. To determine whether PB causes emergent CNS dysfunction, Wistar-Kyoto (WKY) and Sprague-Dawley (SD) rats were given PB for 7 consecutive days in their drinking water. The WKY, but not the SD, rats exhibited a delayed-onset, persistently exaggerated startle response. The WKY rats exhibited exaggerated startle responses that appeared 15 days after the end of PB treatment and were still evident 22 days after the end of treatment. Both the duration and the magnitude of the exaggerated startle responses were related to the dosage of PB. The PB-treated rats exhibited normal short-term and long-term habituation. However, exaggerated startle responses were related to the development of enhanced short-term sensitization. Treating the rats for a second time, 7 weeks after the end of the first PB treatment, induced an exaggerated startle response that appeared sooner and dissipated faster than was evident after the first PB treatment. Inasmuch as the WKY rat has inherently low butyrylcholinesterase activity, a scavenger for PB, these results suggest that prophylactic PB may influence CNS function in individuals with low butyrylcholinesterase activity. Elaboration of the factors that mediate enhanced sensitization in the WKY rat may provide insight into some of the complaints registered by veterans of the Persian Gulf War.


0022-3565/98/2873-1020$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
O. U. Scremin, T.-M. Shih, L. Huynh, M. Roch, R. Booth, and D. J. Jenden
Delayed Neurologic and Behavioral Effects of Subtoxic Doses of Cholinesterase Inhibitors
J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1111 - 1119.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. D. Santos, E. F. R. Pereira, Y. Aracava, N. G. Castro, W. P. Fawcett, W. R. Randall, and E. X. Albuquerque
Low Concentrations of Pyridostigmine Prevent Soman-Induced Inhibition of GABAergic Transmission in the Central Nervous System: Involvement of Muscarinic Receptors
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 254 - 265.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. B. Abou-Donia, A. M. Dechkovskaia, L. B. Goldstein, S. L. Bullman, and W. A. Khan
Sensorimotor Deficit and Cholinergic Changes following Coexposure with Pyridostigmine Bromide and Sarin in Rats
Toxicol. Sci., March 1, 2002; 66(1): 148 - 158.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. B. Abou-Donia, L. B. Goldstein, K. H. Jones, A. A. Abdel-Rahman, T. V. Damodaran, A. M. Dechkovskaia, S. L. Bullman, B. E. Amir, and W. A. Khan
Locomotor and Sensorimotor Performance Deficit in Rats following Exposure to Pyridostigmine Bromide, DEET, and Permethrin, Alone and in Combination
Toxicol. Sci., April 1, 2001; 60(2): 305 - 314.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.